What is Quest Diagnostics Return-on-Tangible-Asset?
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Quest Diagnostics's annualizedNet Income for the quarter that ended in Mar. 2024 was $776 Mil. Quest Diagnostics's average total tangible assets for the quarter that ended in Mar. 2024 was $5,028 Mil. Therefore, Quest Diagnostics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 15.44%.
The historical rank and industry rank for Quest Diagnostics's Return-on-Tangible-Asset or its related term are showing as below:
DGX'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 17.7 Med: 22.5 Max: 35.2
Current: 17.99
During the past 13 years, Quest Diagnostics's highest Return-on-Tangible-Asset was 35.20%. The lowest was 17.70%. And the median was 22.50%.
DGX's Return-on-Tangible-Asset is ranked better than 94.09% of 237
companies
in the Medical Diagnostics & Research industry
Industry Median: -7.85
vs DGX: 17.99
Quest Diagnostics Return-on-Tangible-Asset Historical Data
The historical data trend for Quest Diagnostics's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Quest Diagnostics's Return-on-Tangible-Asset
For the Diagnostics & Research subindustry, Quest Diagnostics's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Diagnostics's Return-on-Tangible-Asset Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Quest Diagnostics's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2024) net income data.
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Quest Diagnostics Return-on-Tangible-Asset Related Terms
Thank you for viewing the detailed overview of Quest Diagnostics's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Quest Diagnostics (Quest Diagnostics) Business Description
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DGX has been successfully added to your 